These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 21630259)

  • 21. Hereditary breast cancer in Finnish women.
    Doepel M; Kellokumpu IH; v Smitten KA
    Eur J Surg; 1995 Nov; 161(11):805-9. PubMed ID: 8749212
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Familial breast carcinoma risks by morphology: a nationwide epidemiologic study from Sweden.
    Hemminki K; Granström C
    Cancer; 2002 Jun; 94(11):3063-70. PubMed ID: 12115398
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Familial risk of cancer shortly after diagnosis of the first familial tumor.
    Bermejo JL; Hemminki K
    J Natl Cancer Inst; 2005 Nov; 97(21):1575-9. PubMed ID: 16264177
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Familial risks of breast and prostate cancers: does the definition of the at risk period matter?
    Brandt A; Bermejo JL; Sundquist J; Hemminki K
    Eur J Cancer; 2010 Mar; 46(4):752-7. PubMed ID: 20022238
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Family history and survival of young women with invasive breast carcinoma.
    Malone KE; Daling JR; Weiss NS; McKnight B; White E; Voigt LF
    Cancer; 1996 Oct; 78(7):1417-25. PubMed ID: 8839546
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Who should not undergo breast conservation?
    Nijenhuis MV; Rutgers EJ
    Breast; 2013 Aug; 22 Suppl 2():S110-4. PubMed ID: 24074770
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Age at diagnosis in relation to survival following breast cancer: a cohort study.
    Brandt J; Garne JP; Tengrup I; Manjer J
    World J Surg Oncol; 2015 Feb; 13():33. PubMed ID: 25889186
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tumor location of the lower-inner quadrant is associated with an impaired survival for women with early-stage breast cancer.
    Sarp S; Fioretta G; Verkooijen HM; Vlastos G; Rapiti E; Schubert H; Sappino AP; Bouchardy C
    Ann Surg Oncol; 2007 Mar; 14(3):1031-9. PubMed ID: 17176985
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Breast cancer prognosis in BRCA1 and BRCA2 mutation carriers: an International Prospective Breast Cancer Family Registry population-based cohort study.
    Goodwin PJ; Phillips KA; West DW; Ennis M; Hopper JL; John EM; O'Malley FP; Milne RL; Andrulis IL; Friedlander ML; Southey MC; Apicella C; Giles GG; Longacre TA
    J Clin Oncol; 2012 Jan; 30(1):19-26. PubMed ID: 22147742
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cancer mortality in relatives of women with breast cancer: the OPCS Study. Office of Population Censuses and Surveys.
    Peto J; Easton DF; Matthews FE; Ford D; Swerdlow AJ
    Int J Cancer; 1996 Jan; 65(3):275-83. PubMed ID: 8575845
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ethnic differences in breast cancer risk and survival: a study on immigrants in Sweden.
    Mousavi SM; Försti A; Sundquist J; Hemminki K
    Acta Oncol; 2013 Nov; 52(8):1637-42. PubMed ID: 23317144
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Concordance of tumour characteristics and survival clustering among pairs of first-degree relatives with breast cancer.
    Rapiti E; Tille JC; Fournier E; Saiji E; Weintraub D; Bouzourene H; Viassolo V; Bouchardy C; Chappuis PO; Benhamou S
    Swiss Med Wkly; 2020 Sep; 150():w20327. PubMed ID: 33035353
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Poor prognosis of single hormone receptor- positive breast cancer: similar outcome as triple-negative breast cancer.
    Bae SY; Kim S; Lee JH; Lee HC; Lee SK; Kil WH; Kim SW; Lee JE; Nam SJ
    BMC Cancer; 2015 Mar; 15():138. PubMed ID: 25880075
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hormone receptor-negative breast cancer: undertreatment of patients over 80.
    Weiss A; Noorbakhsh A; Tokin C; Chang D; Blair SL
    Ann Surg Oncol; 2013 Oct; 20(10):3274-8. PubMed ID: 23838924
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The V89L polymorphism in the 5-alpha-reductase type 2 gene and risk of breast cancer.
    van Gils CH; Onland-Moret NC; Roest M; van Noord PA; Peeters PH
    Cancer Epidemiol Biomarkers Prev; 2003 Nov; 12(11 Pt 1):1194-9. PubMed ID: 14652280
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Overweight and obesity as poor prognostic factors in locally advanced breast cancer patients.
    Arce-Salinas C; Aguilar-Ponce JL; Villarreal-Garza C; Lara-Medina FU; Olvera-Caraza D; Alvarado Miranda A; Flores-Díaz D; Mohar A
    Breast Cancer Res Treat; 2014 Jul; 146(1):183-8. PubMed ID: 24842266
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stage at diagnosis and comorbidity influence breast cancer survival in First Nations women in Ontario, Canada.
    Sheppard AJ; Chiarelli AM; Marrett LD; Nishri ED; Trudeau ME
    Cancer Epidemiol Biomarkers Prev; 2011 Oct; 20(10):2160-7. PubMed ID: 21803843
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Parent of Origin and Prognosis in Familial Breast Cancer in Sweden.
    Wendt C; Lindblom A; Arver B; VON Wachenfeldt A; Margolin S
    Anticancer Res; 2017 Mar; 37(3):1257-1262. PubMed ID: 28314290
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Is survival among women diagnosed with breast cancer influenced by family history of breast cancer?
    Slattery ML; Berry TD; Kerber RA
    Epidemiology; 1993 Nov; 4(6):543-8. PubMed ID: 8268284
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Standardized breast cancer mortality rate compared to the general female population of Iran.
    Haghighat S; Akbari ME; Ghaffari S; Yavari P
    Asian Pac J Cancer Prev; 2012; 13(11):5525-8. PubMed ID: 23317211
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.